GSTP1 and cancer: GSTP1 is overexpressed in multiple cancers (Howells et al., 2004; Ruzza et al., 2009; Wang et al., 2022; Ye et al., 2006), including PDAC, where its high expression is associated with tumor progression and poor clinical outcomes (Singh et al., 2020).